Susan Keeshin

Display Name Susan Keeshin, MD

Position Medical Director, Day Rehabilitation
Assistant Professor, Northwestern University Feinberg School of Medicine
Practicing since 1995
Joined staff in 1995
Phone Number Description Phone

Telephone Number

1-844-355-ABLE

About Me

About Me

Dr. Keeshin Has been an attending physician at the Rehabilitation Institute of Chicago for 21 years. She has a very diverse practice caring for adults with a variety of diagnosis and conditions. She is also the Medical director of the Day Rehabilitation program at RIC, . This program is unique to RIC, where patients are involved in an interdisciplinary, outpatient rehabilitation program led by physicians. She has been involved in a variety of research initiatives including the Model Spinal Cord Injury Grant, the Nextim stoke study focusing on neuromodulation for stroke recovery, and most recently a grant from the American Brain Tumor association, looking at outcomes of Brain Tumor patients in an outpatient rehabilitation setting.

In addition to the address at left, Dr. Keeshin also treats  DayRehab patients at 755 Skokie Boulevard.  Please check your appointment confirmation to ensure you are visiting the correct location. 

Location

Northbrook Outpatient Center

900 Skokie Blvd - Suite 175

Northbrook, IL 60062

Education & Training

    Education

    Credential

    1976 - 1980
    University of Illinois, Urbana, Food and Nutrition
    1988 - 1991
    Rosland Franklin School of medicine/ The Chicago Medical School, Medical Degree
    Residency

    Credential

    1991 - 1995
    Rehabilitation Institute of Chicago/Northwestern University, Physical medicine and rehabilitaion

Honors & Awards

  • Top Doctor
    Chicago Hospital News, 2008
  • Janet Glascow Memorial Citation
    Chicago Medical School, 1991
  • Alpha Omega Alpha Honor Medical Society
    1990

Certificates & Licenses

  • Board Certified Physical Medicine and Rehabilitaion
    ABPMR

Research Interests

  • Stroke recovery and function
  • Rehabilitaion in the brain tumor population